These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
202 related items for PubMed ID: 18940278
1. Prognostic significance of increased left ventricular mass index to mortality and sudden death in patients with stable coronary heart disease (from the Heart and Soul Study). Turakhia MP, Schiller NB, Whooley MA. Am J Cardiol; 2008 Nov 01; 102(9):1131-5. PubMed ID: 18940278 [Abstract] [Full Text] [Related]
2. Echocardiographic left ventricular geometry profiles for prediction of stroke, coronary heart disease and all-cause mortality in the Chinese community: a rural cohort population study. Li T, Li G, Guo X, Li Z, Sun Y. BMC Cardiovasc Disord; 2021 May 12; 21(1):238. PubMed ID: 33980151 [Abstract] [Full Text] [Related]
3. Increased left ventricular mass and hypertrophy are associated with increased risk for sudden death. Haider AW, Larson MG, Benjamin EJ, Levy D. J Am Coll Cardiol; 1998 Nov 12; 32(5):1454-9. PubMed ID: 9809962 [Abstract] [Full Text] [Related]
4. Adverse Cardiac Events and the Impaired Relaxation Left Ventricular Filling Pattern. Lavine SJ, Al Balbissi K. J Am Soc Echocardiogr; 2016 Jul 12; 29(7):699-708. PubMed ID: 27004828 [Abstract] [Full Text] [Related]
5. Prognostic impact of left ventricular mass severity according to the classification proposed by the American Society of Echocardiography/European Association of Echocardiography. Barbieri A, Bursi F, Mantovani F, Valenti C, Quaglia M, Berti E, Marino M, Modena MG. J Am Soc Echocardiogr; 2011 Dec 12; 24(12):1383-91. PubMed ID: 21975437 [Abstract] [Full Text] [Related]
6. Asymptomatic ventricular arrhythmias and mortality risk in subjects with left ventricular hypertrophy. Bikkina M, Larson MG, Levy D. J Am Coll Cardiol; 1993 Oct 12; 22(4):1111-6. PubMed ID: 8409049 [Abstract] [Full Text] [Related]
7. Regression of electrocardiographic left ventricular hypertrophy during antihypertensive therapy and reduction in sudden cardiac death: the LIFE Study. Wachtell K, Okin PM, Olsen MH, Dahlöf B, Devereux RB, Ibsen H, Kjeldsen SE, Lindholm LH, Nieminen MS, Thygesen K. Circulation; 2007 Aug 14; 116(7):700-5. PubMed ID: 17664372 [Abstract] [Full Text] [Related]
8. Persistent left ventricular dilatation in tachycardia-induced cardiomyopathy patients after appropriate treatment and normalization of ejection fraction. Dandamudi G, Rampurwala AY, Mahenthiran J, Miller JM, Das MK. Heart Rhythm; 2008 Aug 14; 5(8):1111-4. PubMed ID: 18675220 [Abstract] [Full Text] [Related]
9. Left ventricular hypertrophy reclassification and death: application of the Recommendation of the American Society of Echocardiography/European Association of Echocardiography. Barbieri A, Bursi F, Mantovani F, Valenti C, Quaglia M, Berti E, Marino M, Modena MG. Eur Heart J Cardiovasc Imaging; 2012 Jan 14; 13(1):109-17. PubMed ID: 21979990 [Abstract] [Full Text] [Related]
10. Left ventricular mass and the risk of sudden cardiac death: a population-based study. Laukkanen JA, Khan H, Kurl S, Willeit P, Karppi J, Ronkainen K, Di Angelantonio E. J Am Heart Assoc; 2014 Nov 05; 3(6):e001285. PubMed ID: 25376188 [Abstract] [Full Text] [Related]
11. Impact of left ventricular cavity size on survival in advanced heart failure. Lee TH, Hamilton MA, Stevenson LW, Moriguchi JD, Fonarow GC, Child JS, Laks H, Walden JA. Am J Cardiol; 1993 Sep 15; 72(9):672-6. PubMed ID: 8249843 [Abstract] [Full Text] [Related]
12. Echocardiographic predictors of clinical outcome in patients with left ventricular dysfunction enrolled in the SOLVD registry and trials: significance of left ventricular hypertrophy. Studies of Left Ventricular Dysfunction. Quiñones MA, Greenberg BH, Kopelen HA, Koilpillai C, Limacher MC, Shindler DM, Shelton BJ, Weiner DH. J Am Coll Cardiol; 2000 Apr 15; 35(5):1237-44. PubMed ID: 10758966 [Abstract] [Full Text] [Related]
13. Limitations of ejection fraction for prediction of sudden death risk in patients with coronary artery disease: lessons from the MUSTT study. Buxton AE, Lee KL, Hafley GE, Pires LA, Fisher JD, Gold MR, Josephson ME, Lehmann MH, Prystowsky EN, MUSTT Investigators. J Am Coll Cardiol; 2007 Sep 18; 50(12):1150-7. PubMed ID: 17868806 [Abstract] [Full Text] [Related]
14. Prediction of All-Cause Mortality by the Left Atrial Volume Index in Patients With Normal Left Ventricular Filling Pressure and Preserved Ejection Fraction. Patel DA, Lavie CJ, Gilliland YE, Shah SB, Dinshaw HK, Milani RV. Mayo Clin Proc; 2015 Nov 18; 90(11):1499-505. PubMed ID: 26455887 [Abstract] [Full Text] [Related]
15. Albuminuria predicts cardiovascular events independently of left ventricular mass in hypertension: a LIFE substudy. Olsen MH, Wachtell K, Bella JN, Palmieri V, Gerdts E, Smith G, Nieminen MS, Dahlöf B, Ibsen H, Devereux RB. J Hum Hypertens; 2004 Jun 18; 18(6):453-9. PubMed ID: 15085167 [Abstract] [Full Text] [Related]
16. Left ventricular architecture and survival in African-Americans free of coronary heart disease (from the Atherosclerosis Risk in Communities [ARIC] study). Taylor HA, Penman AD, Han H, Dele-Michael A, Skelton TN, Fox ER, Benjamin EJ, Arnett DK, Mosley TH. Am J Cardiol; 2007 May 15; 99(10):1413-20. PubMed ID: 17493471 [Abstract] [Full Text] [Related]
18. Electrocardiographic predictors of arrhythmic death and total mortality in the multicenter unsustained tachycardia trial. Zimetbaum PJ, Buxton AE, Batsford W, Fisher JD, Hafley GE, Lee KL, O'Toole MF, Page RL, Reynolds M, Josephson ME. Circulation; 2004 Aug 17; 110(7):766-9. PubMed ID: 15289365 [Abstract] [Full Text] [Related]
19. Sex, age, and disease affect echocardiographic left ventricular mass and systolic function in the free-living elderly. The Cardiovascular Health Study. Gardin JM, Siscovick D, Anton-Culver H, Lynch JC, Smith VE, Klopfenstein HS, Bommer WJ, Fried L, O'Leary D, Manolio TA. Circulation; 1995 Mar 15; 91(6):1739-48. PubMed ID: 7882482 [Abstract] [Full Text] [Related]
20. Prognostic significance of left ventricular mass change during treatment of hypertension. Devereux RB, Wachtell K, Gerdts E, Boman K, Nieminen MS, Papademetriou V, Rokkedal J, Harris K, Aurup P, Dahlöf B. JAMA; 2004 Nov 17; 292(19):2350-6. PubMed ID: 15547162 [Abstract] [Full Text] [Related] Page: [Next] [New Search]